Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
434
mi
from 43215
Atlanta, GA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
434
mi
from 43215
Atlanta, GA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Dana Farber
643
mi
from 43215
Boston, MA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Dana Farber
643
mi
from 43215
Boston, MA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
C.S Mott Children's Hospital
164
mi
from 43215
Ann Arbor, MI
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
C.S Mott Children's Hospital
164
mi
from 43215
Ann Arbor, MI
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Children`s Hospital of Philadelphia : University of Philadelphia
414
mi
from 43215
Philadelphia, PA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Children`s Hospital of Philadelphia : University of Philadelphia
414
mi
from 43215
Philadelphia, PA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
University of Minnesota Medical Center
624
mi
from 43215
Minneapolis, MN
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
University of Minnesota Medical Center
624
mi
from 43215
Minneapolis, MN
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Children's Hospital New York-Presbyterian
481
mi
from 43215
New York, NY
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Children's Hospital New York-Presbyterian
481
mi
from 43215
New York, NY
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
New York University Langone Medical Center
479
mi
from 43215
New York, NY
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
New York University Langone Medical Center
479
mi
from 43215
New York, NY
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Nationwide Children's Hospital in Columbus
3
mi
from 43215
Columbus, OH
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Nationwide Children's Hospital in Columbus
3
mi
from 43215
Columbus, OH
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
St. Jude Childrens Research Hosp, Memphis
507
mi
from 43215
Memphis, TN
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
St. Jude Childrens Research Hosp, Memphis
507
mi
from 43215
Memphis, TN
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Monroe Carell Jr. Children's Hospital at Vanderbilt
331
mi
from 43215
Nashville, TN
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Monroe Carell Jr. Children's Hospital at Vanderbilt
331
mi
from 43215
Nashville, TN
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Usefulnessof Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis
Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis
Status: Archived
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
Usefulnessof Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis
Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis
Status: Archived
Updated: 1/1/1970
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Health Partners Dental Group
635
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Updated: 1/1/1970
Health Partners Dental Group
635
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Health Partners Research Foundation
620
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Updated: 1/1/1970
Health Partners Research Foundation
620
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Kaiser Permanente
1176
mi
from 43215
, CO
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Updated: 1/1/1970
Kaiser Permanente
1176
mi
from 43215
, CO
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Permanente Denrtal Associates
2025
mi
from 43215
Portland, OR
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations
Longitudinal Study of Repaired or Replaced Dental Restorations
Status: Archived
Updated: 1/1/1970
Permanente Denrtal Associates
2025
mi
from 43215
Portland, OR
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Health Partners Dental Group
635
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Updated: 1/1/1970
Health Partners Dental Group
635
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Health Partners Research Foundation
620
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Updated: 1/1/1970
Health Partners Research Foundation
620
mi
from 43215
Minneapolis, MN
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Kaiser Permanente
1176
mi
from 43215
, CO
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Updated: 1/1/1970
Kaiser Permanente
1176
mi
from 43215
, CO
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Permanente Denrtal Associates
2025
mi
from 43215
Portland, OR
DPBRN Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Longitudinal Study of Dental Restorations Placed on Previously Un-restored Surfaces
Status: Archived
Updated: 1/1/1970
Permanente Denrtal Associates
2025
mi
from 43215
Portland, OR
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Burn treatment center
459
mi
from 43215
Iowa City, IA
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Updated: 1/1/1970
Burn treatment center
459
mi
from 43215
Iowa City, IA
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Center for Curative & Palliative Wound Care Calvary Hospital
486
mi
from 43215
New York, NY
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Updated: 1/1/1970
Center for Curative & Palliative Wound Care Calvary Hospital
486
mi
from 43215
New York, NY
Split Thickness Donor Site Pilot Study
A Prospective, Randomized, Controlled Pilot Study of the MIST Therapy System for the Treatment of Split Thickness Donor Sites
Status: Archived
James A. Haley VA Hospital
822
mi
from 43215
Tampa, FL
Split Thickness Donor Site Pilot Study
A Prospective, Randomized, Controlled Pilot Study of the MIST Therapy System for the Treatment of Split Thickness Donor Sites
Status: Archived
Updated: 1/1/1970
James A. Haley VA Hospital
822
mi
from 43215
Tampa, FL
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical Procedures
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical Procedures
Status: Archived
UC San Diego Medical Center
1951
mi
from 43215
San Diego, CA
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical Procedures
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical Procedures
Status: Archived
Updated: 1/1/1970
UC San Diego Medical Center
1951
mi
from 43215
San Diego, CA
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis
The Atopic Dermatitis Clinic as an Entry Point for Community Outreach in Asthma, Missed Immunizations, and Vitamin D Deficiency
Status: Archived
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis
The Atopic Dermatitis Clinic as an Entry Point for Community Outreach in Asthma, Missed Immunizations, and Vitamin D Deficiency
Status: Archived
Updated: 1/1/1970
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
Investigations of Botanicals on Food Intake, Satiety, Weight Loss, and Oxidative Stress
Investigations of Botanicals on Food Intake, Satiety, Weight Loss, and Oxidative Stress
Status: Archived
University of Florida Shands Hospital
716
mi
from 43215
Gainesville, FL
Investigations of Botanicals on Food Intake, Satiety, Weight Loss, and Oxidative Stress
Investigations of Botanicals on Food Intake, Satiety, Weight Loss, and Oxidative Stress
Status: Archived
Updated: 1/1/1970
University of Florida Shands Hospital
716
mi
from 43215
Gainesville, FL
Vitamin D Supplementation in Breastfeeding Women
Maternal Oral Vitamin D Supplementation Via Daily or Monthly Regimens and the Effect on Levels of Vitamin D in Human Milk and Infant Serum
Status: Archived
Mayo Clinic College of Medicine
559
mi
from 43215
Rochester, MN
Vitamin D Supplementation in Breastfeeding Women
Maternal Oral Vitamin D Supplementation Via Daily or Monthly Regimens and the Effect on Levels of Vitamin D in Human Milk and Infant Serum
Status: Archived
Updated: 1/1/1970
Mayo Clinic College of Medicine
559
mi
from 43215
Rochester, MN
Vitamin D in HIV-Infected Patients on HAART
Vitamin D, Immune Activation, and Metabolic Abnormalities in HIV-Infected Patients on Antiretroviral Therapy
Status: Archived
UCLA Center for Clinical AIDS Research and Education (CARE) Clinic
1979
mi
from 43215
Los Angeles, CA
Vitamin D in HIV-Infected Patients on HAART
Vitamin D, Immune Activation, and Metabolic Abnormalities in HIV-Infected Patients on Antiretroviral Therapy
Status: Archived
Updated: 1/1/1970
UCLA Center for Clinical AIDS Research and Education (CARE) Clinic
1979
mi
from 43215
Los Angeles, CA
Ketones & Mitochondrial Heteroplasmy
Ketones & Mitochondrial Heteroplasmy
Status: Archived
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Ketones & Mitochondrial Heteroplasmy
Ketones & Mitochondrial Heteroplasmy
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
East Bay Perinatal Medical Associates
2098
mi
from 43215
Oakland, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Updated: 1/1/1970
East Bay Perinatal Medical Associates
2098
mi
from 43215
Oakland, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Prenatal Diagnosis of Northern California
2040
mi
from 43215
Sacramento, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Updated: 1/1/1970
Prenatal Diagnosis of Northern California
2040
mi
from 43215
Sacramento, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
UC San Diego Medical Center
1951
mi
from 43215
San Diego, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Updated: 1/1/1970
UC San Diego Medical Center
1951
mi
from 43215
San Diego, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
University of California - San Francisco
2109
mi
from 43215
San Francisco, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Updated: 1/1/1970
University of California - San Francisco
2109
mi
from 43215
San Francisco, CA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Atlanta Perinatal Consultants
427
mi
from 43215
Atlanta, GA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Updated: 1/1/1970
Atlanta Perinatal Consultants
427
mi
from 43215
Atlanta, GA
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
Status: Archived
Updated: 1/1/1970
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin
A Phase 1 Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-05230901 Administered Subcutaneously To Healthy Subjects
Status: Archived
Pfizer Investigational Site
522
mi
from 43215
Bridgeport, CT
A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin
A Phase 1 Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-05230901 Administered Subcutaneously To Healthy Subjects
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
522
mi
from 43215
Bridgeport, CT
Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
Regional Cerebral Utilization of Glucose in Patients With a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
Regional Cerebral Utilization of Glucose in Patients With a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
Induction of Mixed Hematopoietic Chimerism in Patients With Severe Combined Immunodeficiency Disorders Using Allogeneic Bone Marrow and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated:  12/31/1969
Fred Hutch/University of Washington Cancer Consortium
2003
mi
from 43215
Seattle, WA
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
Induction of Mixed Hematopoietic Chimerism in Patients With Severe Combined Immunodeficiency Disorders Using Allogeneic Bone Marrow and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
2003
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Vinblastine/Methotrexate For Severe Progressive Plexiform Neurofibromas: A Phase II Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Vinblastine/Methotrexate For Severe Progressive Plexiform Neurofibromas: A Phase II Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated:  12/31/1969
Rebecca and John Moores UCSD Cancer Center
1950
mi
from 43215
La Jolla, CA
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated: 12/31/1969
Rebecca and John Moores UCSD Cancer Center
1950
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated:  12/31/1969
Camino Medical Group - Treatment Center
2097
mi
from 43215
Mountain View, CA
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated: 12/31/1969
Camino Medical Group - Treatment Center
2097
mi
from 43215
Mountain View, CA
Click here to add this to my saved trials
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Medical Office -Vandever Medical Office
1944
mi
from 43215
San Diego, CA
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Medical Office -Vandever Medical Office
1944
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated:  12/31/1969
Naval Medical Center - San Diego
1951
mi
from 43215
San Diego, CA
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients
Status: Enrolling
Updated: 12/31/1969
Naval Medical Center - San Diego
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials